The present work is the first phytochemical investigation of Euphorbia davidii Subils. After multistep separation process, three flavonoid glycosides were obtained from the ethyl acetate soluble fraction of the methanol extract of the whole plant. The structures of the isolated compounds were determined as kaempferol 3-O-rhamnoside, myricetin 3-O-rhamnoside, and quercetin 3-O-rhamnoside. Aqueous and organic extracts of the plant were screened in vitro for antiproliferative activity against HeLa (cervix epithelial adenocarcinoma), A431 (skin epidermoid carcinoma), A2780 (ovarian carcinoma) and MCF7 (breast epithelial adenocarcinoma) cells, using the MTT assay. n-Hexane and chloroform extracts demonstrated moderately dose-dependent cell growth inhibitory activity against all four cell lines.
the subsection Stormieae within the Euphorbia section Poinsettia [12] . Neither the phytochemical investigation of E. davidii nor its biological activity have been reported previously.
Extensive phytochemical investigation was performed, in order to identify characteristic secondary metabolites of E. davidii. The whole plants were collected in Igar, Hungary, in September 2011. A herbarium sample (No. 836) has been deposited in the Department of Pharmacognosy, University of Szeged, Szeged, Hungary. The frozen fresh plant (15 kg) was percolated with 15 L methanol at room temperature. The crude extract was concentrated in vacuum and water was then added. The chlorophyll was removed by liquid-liquid extraction using CHCl 3 (5 × 1500 mL). The aqueous methanolic residue was extracted with ethyl acetate (5 × 1000 mL). Structures of 1-3 were established by NMR spectroscopy (Bruker Avance DRX 500 spectrometer, δ in ppm rel. to Me 4 Si as internal standard, J in Hz). The 1 H-and 13 C-NMR data of isolated compounds were identical with those of kaempferol 3-O-rhamnoside [10] , quercetin-O-rhamnoside [4, 5] , and myricetin 3-O-rhamnoside [6] (Fig. 1) . 
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For pharmacological investigations 50 g of fresh plant material was extracted with 500 mL methanol with the use of an ultrasonic bath. After filtration, the extract was evaporated to dryness under reduced pressure. The residue was dissolved in 50 mL 50% aqueous methanol and was subjected to solvent-solvent partition between n-hexane (3×50 mL) and chloroform (3 × 50 mL). The n-hexane, chloroform and the residue phases were evaporated to dryness. After extraction with methanol, the dried plant material was extracted with 400 mL of boiling water for 15 min. The filtered extract was freeze-dried. All five extracts were screened in vitro for antiproliferative activity against HeLa (cervix epithelial adenocarcinoma), A431 (skin epidermoid carcinoma), A2780 (ovarian carcinoma) and MCF7 (breast epithelial adenocarcinoma) cells by using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay [8] . All in vitro experiments were carried out on two microplates with at least five parallel wells. Cisplatin was used as reference compound. Stock solutions of the tested extracts (10 mg/mL) were prepared with DMSO. The cell lines were treated with extracts at concentrations of 10 or 30 mg/mL. The higher concentration of DMSO (0.3%) did not exert substantial action on the viability of the utilized cell lines [7] . Antiproliferative effects of extracts are presented in Table 1 .
In the course of our previous chemical screenings, 33 Euphorbiaceae species were tested for their diterpene content using the extraction and chromatographic methods published in ref. [11] . This investigation suggested, that diterpenes are not detectable in the extract of E. davidii [11] . Extensive literature searches on all species belonging to the section Poinsettia led to the conclusion that plants of this section are poorly investigated, and characteristic metabolites of this section are flavonoids and triterpenoids. Isolation of three flavonoid gylcosides from E. davidii confirms this establishment. In our pharmacological investigation flavonoid containing ethyl acetate extract did not inhibit the proliferation of any cancer cell lines. However, n-hexane and chloroform extracts demonstrated dose-dependent cell growth inhibitory activity against all cell lines. Bioassay guided phytochemical investigation of these lipophilic extracts would be a proper way of finding antiproliferative agents of E. davidii.
